InsidersTradesSigma
Across 1 buy signal with a settled T+90 return. Return basis: close on the day after publication.
No signal scores available.
Discover the full record of transactions filed by Hallock Kenneth, Director. Director active across 1 company, notably Greenwich LifeSciences, Inc.. In total, 1 reports have been recorded. Breakdown: 1 buy · 0 sell. Total volume traded: €4k. History available since 21 January 2022. The latest transaction was disclosed on 21 January 2022 (Acquisition). Regulator: SEC (Form 4). All data is accessible without signup.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
1 of 1 declaration
Kenneth Hallock is a Director at Greenwich LifeSciences, Inc. In this role, he participates in overseeing the company's activities and making strategic decisions. With expertise in the life sciences field, he brings valuable insights to the board, contributing to the company's strategic direction.